Plasma homocysteine concentrations in a population with a low coronary heart disease prevalence

J B Ubbink1, R Delport, W J Vermaak

  • 1Department of Chemical Pathology, University of Pretoria, South Africa.

Insights

Black South Africans have lower plasma homocysteine levels and better homocysteine metabolism than White South Africans. This may explain their lower risk of coronary heart disease.

Area of Science:

  • Cardiovascular Science
  • Nutritional Biochemistry
  • Population Health

Background:

  • Coronary heart disease (CHD) prevalence varies significantly between populations.
  • Hyperhomocysteinemia is a potential risk factor for CHD.
  • South African Black and White populations exhibit differing CHD prevalence.

Purpose of the Study:

  • To investigate hyperhomocysteinemia as a potential CHD risk factor.
  • To compare plasma homocysteine levels and metabolism between South African Black and White populations.
  • To explore the relationship between homocysteine levels and CHD resistance.

Main Methods:

  • Comparative analysis of plasma homocysteine concentrations in adult Black men and White individuals.
  • Assessment of plasma homocysteine frequency distributions in children and adults.
  • Oral methionine load tests to evaluate homocysteine metabolism and identify methionine intolerance.

Main Results:

  • Significantly lower plasma homocysteine concentrations were observed in traditionally living adult Black men compared to Whites.
  • Plasma homocysteine distribution in Whites was positively skewed, suggesting acquired elevations in adulthood, unlike the normal distribution in children.
  • Young adult Whites exhibited methionine intolerance, indicated by elevated plasma homocysteine post-methionine load, unlike Black individuals.

Conclusions:

  • Black South Africans generally maintain lower circulating plasma homocysteine concentrations.
  • Black South Africans demonstrate more effective homocysteine metabolism following oral methionine loading.
  • These findings suggest that lower homocysteine levels and efficient metabolism may contribute to the relative resistance of Black South Africans to coronary heart disease.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...